Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Centrum für Operative Urologie Bremen | Researchclopedia

Back to institutions

Centrum für Operative Urologie Bremen

Bremenfacility

27

Works

465

Citations

10

h-index

Top Research Topics

Renal cell carcinoma treatment Renal and related cancers Cancer Genomics and Diagnostics

Top Researchers

G. Mickisch Centrum für Operative Urologie Bremen

153 works3,255 citationsh-index: 29

Recent Research

Between research and introduction to clinical routine—Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis)

Jacek Grabowski,Julia Welz,et al.

20260 citations

Bladder and Urothelial Cancer Treatments

Prostate Cancer Treatment and Research

Economic and Financial Impacts of Cancer

Radiopharmaceutical Chemistry and Applications

Prostate Cancer Diagnosis and Treatment

Sexual Differentiation and Disorders

Cancer-related gene regulation

Cancer Immunotherapy and Biomarkers

Pancreatic and Hepatic Oncology Research

Christian Lorenz Leipzig University

124 works1,962 citationsh-index: 24

22 works194 citationsh-index: 4

Cristina Hettwer Centrum für Operative Urologie Bremen

1 works0 citationsh-index: 0

Erratum zu: Immuntherapie und Tyrosinkinaseinhibitoren beim metastasierten Nierenzellkarzinom in der First-line-Therapie – Wann welche Strategie?

G. Mickisch,Inga Peters,et al.

20210 citations

Immuntherapie und Tyrosinkinaseinhibitoren beim metastasierten Nierenzellkarzinom in der First-line-Therapie – Wann welche Strategie?

G. Mickisch,Inga Peters,et al.

20202 citations

CARD-Studie – Bedeutung für die Therapie des fortgeschrittenen Prostatakarzinoms

Axel S. Merseburger,A. Bannowsky,et al.

20200 citations

Metastasiertes kastrationsresistentes Prostatakarzinom

K. Miller,Peter Albers,et al.

20161 citations

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior Treatment With Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Kyriaki Tzogani,Venke Skibeli,et al.

201541 citations